PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,772.50
Bid: 1,772.00
Ask: 1,772.50
Change: -11.00 (-0.62%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European shares end fifth week higher on rate-cut optimism

Fri, 15th Dec 2023 17:08

Barclays sees first ECB rate cut in April

*

Villeroy: Next ECB move should be a cut; 'enjoy' the plateau

*

Sweden's Sectra tops STOXX 600 after Q2 report

*

Symrise slides on EBITDA margin outlook cut

Dec 15 (Reuters) -

European shares inched up on the final day of a week marked by major central bank policy decisions, in which the U.S. Federal Reserve set the tone for market expectations about interest rate cuts being on the horizon.

The pan-European STOXX 600 edged 0.1% higher on Friday, posting its fifth straight weekly advance and recording its longest weekly winning streak since April.

The German benchmark DAX was flat, while France's CAC-40 climbed 0.3% after both hit record highs on Thursday.

For the week, rate-sensitive real estate stocks were the top gainers, while the telecommunication sector took the worst hit.

On the policy front, the Fed stood out, signalling lower borrowing costs in 2024, while the European Central Bank held rates steady, pushing back against rate-cut bets on Thursday.

"Our economists see... the hawkish tilt of (Thursday's ECB meeting) as reducing the risk of the ECB cutting as soon as March, but retain their view of rate cuts starting in April with 150 bps of cuts by the end of next year," Deutsche Bank said in a note.

Barclays forecast a 25-basis-point ECB rate cut in April and consecutive cuts in each policy meeting until January 2025.

Meanwhile, ECB policymaker Francois Villeroy de Galhau said although the ECB's next move should be lowering rates, it should first "enjoy the view" for a while.

Economic concerns were underscored by weak data showing Germany's economic downturn worsened this month, pointing to a recession in Europe's biggest economy at the year-end, and French business activity declined faster than expected in December.

Weakness in the healthcare sector weighed for the day, with UK-based

GSK

slipping 2.9% after EU regulator pulled the plug on company's blood cancer drug.

Swedish technology firm Sectra jumped 8.3% to the top of STOXX 600 following second-quarter results.

Stockholm-listed receipts of Millicom gained 2.7% after the telecom group raised its target and launched a share buyback program.

EQT rose 4.3% after J.P. Morgan upgraded the Swedish private equity firm to "neutral" from "underweight".

Symrise lost 7.6% after the German flavour and fragrance maker cut its full-year EBITDA margin guidance.

Campari shed 2.9% after the Italian spirits group announced its biggest-ever acquisition to buy French cognac house Courvoisier for $1.2 billion. (Reporting by Ankika Biswas and Bansari Mayur Kamdar in Bengaluru; Editing by Janane Venkatraman and Andrew Heavens)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.